Florian Vogl

No open positions remaining

Health Technology

Consumer Services

Profile

Dr. Florian D.
Vogl was previously employed as a Chief Medical Officer by Immutep Ltd., a Chief Medical Officer by Cellestia Biotech AG, and a Head-Clinical Development Europe by Rainier Therapeutics, Inc. He received his doctorate degree from Ludwig-Maximilians-Universität München.

Former positions of Florian Vogl

Companies	Position	End
Cellestia Biotech AG Cellestia Biotech AG Pharmaceuticals: MajorHealth Technology Manufactures anti-cancer drugs	Chief Tech/Sci/R&D Officer	01/05/2023
Rainier Therapeutics, Inc. Rainier Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company developing a targeted biologic for the potential treatment of both early stage and metastatic bladder cancer	Corporate Officer/Principal	01/12/2019
IMMUTEP LIMITED	Chief Tech/Sci/R&D Officer	-

See the detail of Florian Vogl's experience

Training of Florian Vogl

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Florian Vogl's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Immutep Ltd. Immutep Ltd. BiotechnologyHealth Technology Engages in the development of anti-cancer therapeutics	Health Technology
Ludwig-Maximilians-Universität München Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Rainier Therapeutics, Inc. Rainier Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company developing a targeted biologic for the potential treatment of both early stage and metastatic bladder cancer	Health Technology
Cellestia Biotech AG Cellestia Biotech AG Pharmaceuticals: MajorHealth Technology Manufactures anti-cancer drugs	Health Technology